Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filovirus Infections”

106 trials

Showing 20 of 106 results

Early research (Phase 1)Study completedNCT05079750
What this trial is testing

A New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 26
Testing effectiveness (Phase 2)Study completedNCT02329054
What this trial is testing

Efficacy of Favipiravir Against Ebola (JIKI)

Who this might be right for
Ebola Virus Disease
Institut National de la Santé Et de la Recherche Médicale, France 126
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Early research (Phase 1)Study completedNCT02319772
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

Who this might be right for
Filovirus InfectionsEbola Virus Infection
BioCryst Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT05817422
What this trial is testing

Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 126
Early research (Phase 1)Ended earlyNCT02295501
What this trial is testing

A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease

Who this might be right for
Acute Ebola Virus Disease
Cerus Corporation 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT06620003
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 200
Not applicableStudy completedNCT04409405
What this trial is testing

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)

Who this might be right for
Ebola Virus Disease
Institut National de la Santé Et de la Recherche Médicale, France 787
Testing effectiveness (Phase 2)WithdrawnNCT04268966
What this trial is testing

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

Who this might be right for
Ebola Virus Disease
Jazz Pharmaceuticals
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Post-approval studies (Phase 4)Looking for participantsNCT05992480
What this trial is testing

REVIVE (Response to the Ebola Virus Vaccine)

Who this might be right for
Ebola Virus Disease
Tulane University 40
Not applicableStudy completedNCT03820739
What this trial is testing

EBOVAC-Salone Extension

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 653
Early research (Phase 1)Study completedNCT02370589
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Who this might be right for
Ebola
Novavax 230
Testing effectiveness (Phase 2)Study completedNCT03929757
What this trial is testing

2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 108
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Early research (Phase 1)Study completedNCT03583606
What this trial is testing

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Who this might be right for
Ebola DiseaseImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 61
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841614
What this trial is testing

EBOla Post-Exposure Prophylaxis

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 160
Large-scale testing (Phase 3)Ended earlyNCT02661464
What this trial is testing

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 677
Early research (Phase 1)Study completedNCT02408913
What this trial is testing

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 140
Large-scale testing (Phase 3)WithdrawnNCT02307591
What this trial is testing

Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

Who this might be right for
Ebola Virus Disease
Emergency NGO Onlus
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation